Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37865050)

  • 1. Survival outcomes and establishment of a novel risk stratification system in patients with ovarian yolk sac tumors.
    Li S; Zhang X; Zhang T; Zhang R; Cao D; Xiang Y; Yang J
    Gynecol Oncol; 2023 Nov; 178():145-152. PubMed ID: 37865050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Component Patterns and Survival Outcomes in Patients with Mixed Malignant Ovarian Germ Cell Tumors: A Retrospective Cohort Study.
    Li S; Zhang R; Zhang X; Zhang T; Cao D; Xiang Y; Yang J
    Clin Oncol (R Coll Radiol); 2024 Jun; 36(6):370-377. PubMed ID: 38555208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of an early decline in serum alpha-fetoprotein during chemotherapy for ovarian yolk sac tumors.
    de la Motte Rouge T; Pautier P; Genestie C; Rey A; Gouy S; Leary A; Haie-Meder C; Kerbrat P; Culine S; Fizazi K; Lhommé C
    Gynecol Oncol; 2016 Sep; 142(3):452-7. PubMed ID: 27401840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical analysis of 12 cases of ovarian yolk sac tumor].
    Liu J; Chu HJ; Shan YP; Song WJ; Chen AP
    Zhonghua Fu Chan Ke Za Zhi; 2024 Mar; 59(3):210-214. PubMed ID: 38544450
    [No Abstract]   [Full Text] [Related]  

  • 5. Ovarian Yolk Sac Tumor: The Experience of a Regional Cancer Center.
    Wang X; Ma Z; Li Y
    Int J Gynecol Cancer; 2016 Jun; 26(5):884-91. PubMed ID: 27104939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of neoadjuvant chemotherapy in the management of advanced ovarian yolk sac tumor.
    Lu Y; Yang J; Cao D; Huang H; Wu M; You Y; Chen J; Lang J; Shen K
    Gynecol Oncol; 2014 Jul; 134(1):78-83. PubMed ID: 24582864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors of patients with yolk sac tumors of the ovary.
    Nawa A; Obata N; Kikkawa F; Kawai M; Nagasaka T; Goto S; Nishimori K; Nakashima N
    Am J Obstet Gynecol; 2001 May; 184(6):1182-8. PubMed ID: 11349186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian Yolk Sac Tumors; Does Age Matter?
    Faure Conter C; Xia C; Gershenson D; Hurteau J; Covens A; Pashankar F; Krailo M; Billmire D; Patte C; Fresneau B; Shaikh F; Stoneham S; Nicholson J; Murray M; Frazier AL
    Int J Gynecol Cancer; 2018 Jan; 28(1):77-84. PubMed ID: 29194189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of serum α-fetoprotein in ovarian yolk sac tumors: A systematic review and meta-analysis.
    Guo YL; Zhang YL; Zhu JQ
    Mol Clin Oncol; 2015 Jan; 3(1):125-132. PubMed ID: 25469282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Residual tumor after the salvage surgery is the major risk factors for primary treatment failure in malignant ovarian germ cell tumors: a retrospective study of single institution.
    Lee CW; Song MJ; Park ST; Ki EY; Lee SJ; Lee KH; Ryu KS; Park JS; Hur SY
    World J Surg Oncol; 2011 Oct; 9():123. PubMed ID: 21988930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome and prognostic factors for yolk sac tumor of the ovary.
    Umezu T; Kajiyama H; Terauchi M; Shibata K; Ino K; Nawa A; Kikkawa F
    Nagoya J Med Sci; 2008 Mar; 70(1-2):29-34. PubMed ID: 18807293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revised risk classification for pediatric extracranial germ cell tumors based on 25 years of clinical trial data from the United Kingdom and United States.
    Frazier AL; Hale JP; Rodriguez-Galindo C; Dang H; Olson T; Murray MJ; Amatruda JF; Thornton C; Arul GS; Billmire D; Shaikh F; Pashankar F; Stoneham S; Krailo M; Nicholson JC
    J Clin Oncol; 2015 Jan; 33(2):195-201. PubMed ID: 25452439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic Characteristics and Survival of Patients with Rare Malignant Ovarian Yolk Sac Tumors: A Population-based Analysis.
    Wang T; Wang B; Wang SX; Wu MF
    Curr Med Sci; 2021 Apr; 41(2):342-347. PubMed ID: 33877552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors in women treated for ovarian yolk sac tumour: a retrospective analysis of 84 cases.
    de La Motte Rouge T; Pautier P; Rey A; Duvillard P; Kerbrat P; Troalen F; Morice P; Haie-Meder C; Culine S; Lhommé C
    Eur J Cancer; 2011 Jan; 47(2):175-82. PubMed ID: 20851596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Need for risk-adapted therapy for malignant ovarian germ cell tumors: A large multicenter analysis of germ cell tumors' patients from French TMRG network.
    Derquin F; Floquet A; Hardy-Bessard AC; Edeline J; Lotz JP; Alexandre J; Pautier P; Angeles MA; Delanoy N; Lefeuvre-Plesse C; Cancel M; Treilleux I; Augereau P; Lavoue V; Kalbacher E; Berton Rigaud D; Selle F; Nadeau C; Gantzer J; Joly F; Guillemet C; Pomel C; Favier L; Abdeddaim C; Venat-Bouvet L; Provansal M; Fabbro M; Kaminsky MC; Lortholary A; Lecuru F; Coquard IR; de La Motte Rouge T
    Gynecol Oncol; 2020 Sep; 158(3):666-672. PubMed ID: 32624235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management and prognosis of ovarian yolk sac tumors; an analysis of the National Cancer Data Base.
    Nasioudis D; Chapman-Davis E; Frey MK; Caputo TA; Holcomb K
    Gynecol Oncol; 2017 Nov; 147(2):296-301. PubMed ID: 28803748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum alphafetoprotein (AFP) in patients with germ cell tumors of the gonads and extragonadal sites: correlation between endodermal sinus (yolk sac) tumor and raised serum AFP.
    Talerman A; Haije WG; Baggerman L
    Cancer; 1980 Jul; 46(2):380-5. PubMed ID: 6155988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging in gynecological disease (17): ultrasound features of malignant ovarian yolk sac tumors (endodermal sinus tumors).
    Anfelter P; Testa A; Chiappa V; Froyman W; Fruscio R; Guerriero S; Alcazar JL; Mascillini F; Pascual MA; Sibal M; Savelli L; Zannoni GF; Timmerman D; Epstein E
    Ultrasound Obstet Gynecol; 2020 Aug; 56(2):276-284. PubMed ID: 32119168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment and characterization of an ovarian yolk sac tumor patient-derived xenograft model.
    Luo M; He Y; Xie B; Li S; Gan F; Zhang S; Luo P
    Pediatr Surg Int; 2021 Aug; 37(8):1031-1040. PubMed ID: 34031745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological features, prognosis, and fertility outcomes in Chinese Han women treated for ovarian yolk sac tumor: A retrospective case series study from two tertiary-care academic medical centers.
    Qin L; Wang B; Wang Z; He D
    Medicine (Baltimore); 2022 Jul; 101(29):e29868. PubMed ID: 35866762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.